Weekly Fundamental and Technical Analysis Prospects - Week Starting 13th Apr 2015 (No. 161)
Here’s this week’s FA and TA List. The newer items first and those carried forward from last week towards back of list (some of the items from last week have a time horizon of more that one week).
All listed market caps are undiluted (and do not include escrowed shares) (Note: Max time for any entry on list will be 4 weeks after which time it will be removed).
Important Note: Remember just because it appears on the list does not necessarily mean it will rise in price... it may actually fall or do nothing. So it is critical that you perform detailed research on each stock first and make your own mind up to whether invest or not. I suggest you run a stop-loss at all times when trading/investing. How tight your stops are depends on your threshold to risk and financial pain. Lastly I take no responsibility for the accuracy of the information provided as I do not have the time to research all the facts that have been provided. Best of Luck.!
Weekly Fundamental Analysis Prospects
NLS - Health [13/04/2015]
Narhex Life Sciences. mHealth (global, will apply for FDA approval) Diagnosis and Management of Respiratory Disease Using Smartphones. $5.2 million market cap at 0.9c, $0.37 million cash NLS is the commercialisation vehicle for ResApp, a technology being commercialised by UniQuest (Uni of Qld). Uniquest commercialised Gardisal through CSL and is receiving revenues from 30 Uni of Qld developed technologies. The Melinda and Bill Gates Foundation funded the initial research, which diagnoses the kind of respiratory illness you have by coughing into your smartphone. It is currently being optimised by clinical testing at a Perth hospital. Commercialisation via FDA approval is planned within 18 months. On Friday, Jason Peterson turned up via a substantial shareholder notice as owning 9% of the company. NSL plans to raise $2.5 million through a compliance raising at 1c. As the price is now 0.8c / 0/9c, there is every likelihood of a pump to 1.2c or so to get the placement away. This is the only product of its kind globally, so I think $5 million is just too low for a company with the credentials and potential of ResApp. You would think they could come up with a better name though.
Poster: Umizoomi (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15073337/single (Mcap: $5.4m)
XTD - Transport Digital Advertising [13/04/2015]
XTD-XTD Limited MC-$29 mill SP-19.5c Cash-$1.9 mill XTD installs and operates cross track digital media screens designed for metropolitan railway station platforms. This provides new revenue streams for metro railway operators and currently cash flow positive after rollout has commenced across several Australian rail networks. International expansion particularly the USA market will be the key growth driver and currently in discussion with advertising groups and media buyers for the potential large scale rollout across overseas markets. Also developing several Apps for rail commenters. http://www.asx.com.au/asxpdf/20150303/pdf/42x11hbgy9zrzg.pdf
Poster: Ormond (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15072798/single (Mcap: $15.2m)
ADV - Graphite in Canada, Head Quarters in Perth, WA. [13/04/2015]
Market cap approx. $3.3mil- last price $0.009 Cash on hand aprrox. $450K Formerly Stratos Resources, the co. previously was focussed on Tin projects and a coal project in Canada. The company now has a focus on GRAPHITE IN ONTARIO, CANADA. Their recently acquired graphite project had not been previously drilled, however, historical metallurgical testing has indicated jumbo and large flake graphite. ADV commenced drilling the targets and announced on 8th April that the drilling has been completed with visual evidence of SUPER JUMBO and JUMBO size flakes. ASSAY RESULTS DUE THIS WEEK. This tip is a high risk punt on results due. Enterprise value is a super low $2 to 3million and if results are good there could be significant upside. Project based in a established mining area with good infrastructure. Trading volumes on this are still surprisingly low, this one seems to be going unnoticed. Graphite sector of interest again following TON's gains (and losses).
Poster: OnePipWonder (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15073639/single (Mcap: $3.3m)
MOX - Explorer for minerals in South Aust [13/04/2015]
sp = 1.3c cash = $1.4M @ Dec 2014 shares = 214M MC = $2.7M FA drilling commenced 2 weeks ago at Millers creek, a joint project with a Chilean copper producer. results expected in 4-5 week, should see a price rise in anticipation. sp spiked in anticipation of another project update in January.
Poster: Marty386 (STT Accuracy: 38.7% - Ranking No.11 ) http://hotcopper.com.au/posts/15072510/single (Mcap: $2.8m)
GMM - Iron ore, gold, copper, cabonatite and tantalum -[Australia] [10/04/2015]
MC- $7.15 mill Cash – $908K (after recent oversubscribed placement at 0.05) SP – 0.047 Has closed on the previous support line, so I anticipate a reversal from here based on progress being made with the Cattlin Tantalum project. Anticipated early target is 0.062 (recent top of range and resistance line). Secondary target 0.07. See Chart in Link
Poster: Trevor12 (STT Accuracy: 30.8% - Ranking No.15 ) http://hotcopper.com.au/posts/15061037/single (Mcap: $7.2m)
GMM - Iron ore, gold, copper, cabonatite and tantalum -[Australia]
[10/04/2015]
MC- $7.15 mill Cash – $908K (after recent oversubscribed placement at 0.05) SP – 0.047Currently have sole right to operate at the Mt Cattlin Tantalum project with option to purchase. Have now completed due diligence and moved into 3 month development period. Anticipate production by August. Fully funded through to final development decision expected by 1.7.2015 (have raised $900K recently)
Poster: Trevor12 (STT Accuracy: 30.8% - Ranking No.15 ) http://hotcopper.com.au/posts/15061037/single (Mcap: $7.2m)
BCI - Iron Ore in the Pilbara WA [10/04/2015]
MC- $57.9 mill Cash – $107.5million - with debt $35.8million (31.3.2015 – Quarterly update) SP – 0.295Quarterly update today outlining better than expected shipment rate and effective production cost reduction. Well accepted by the market regardless of decreasing ore price.
Poster: Trevor12 (STT Accuracy: 30.8% - Ranking No.15 ) http://hotcopper.com.au/posts/15061223/single (Mcap: $54m)
PHK - Clean Water Tech [10/04/2015]
MKT CAP: 10M CASH: 1M Phoslock is a patented chemical technology that starves algae in a water body. This occurs as it binds to phosphorous, which algae feeds on. Recent announcements allude to 22 small contracts as well as 10 large contracts being negotiated/in late stages. Any large contract win should see a big spike in share price as Phoslock is only capped at 10M. On top of this, Chinas Government is putting forward its official plan within in the next month to use $320 billion USD to clean up its water systems from which some interest should flow to water stocks regardless of if contracts are won or not.
Poster: Third (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15059706/single (Mcap: $10.1m)
ADV - Mining (Graphite mainly). [9/04/2015]
MC: $2.5m CASH: $500k approx Sector: Mining (Graphite mainly). Top 20 own 56% with 167m remaining. Breakout today after the announcement below in the afternoon trade including a closing 27k buy at the ask to finish off. Drilling program commenced in early March with results expected next week as noted below. Should see a sharp spike with Graphite being a flavour of the month in anticipation. Drilling program fully funded as well. Excerpt from announcement today:Ardiden Limited (ASX: ADV) is pleased to advise that the maiden drilling program at the Company’s 100%-owned Manitouwadge Graphite Project in Ontario, Canada, has now been completed, and results from the petrographic report have been received. The petrographic report includes visual evidence of the presence of jumbo and superjumbo flake graphite from the recently completed drill program. Highlights? Maiden drilling program now completed at Ardiden’s 100%-owned Manitouwadge Graphite Project in Ontario, Canada. ? Petrographic report received on core samples shows visual evidence of jumbo flake size graphite, including super-jumbo flake sizes up to 1,000 µm. ? All core samples have been sent to lab, with assays and beneficiation results currently pending. Initial assay results are currently expected in the next week. ? Samples from maiden drill program will be beneficiated and forwarded to potential customers/traders for market and pricing feedback.
Poster: Mroberts1969 (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15054169/single (Mcap: $3.3m)
RGS - Biotech [8/04/2015]
Regeneus LTD is an undervalued bio stock. I owned this stock when it was trading in the mid 30's a while back. Now at these price levels and given the FA, it is great value imho. It reminds me of CYP, another bio stock that i held for a while and also traded multiple times. MC of RGS ~ $29M vs MC of CYP ~ $76M. RGS arguably has the superior product with cells that have no issues. The company raised at 26c not so long back with the outlook of taking the SP to 45c plus. Dr Glen Richards, one of the directors purchased $1.1M shares last week at 0.15c and I wouldn't blame him because the SP looks very cheap at these levels.Regeneus achieves key stem cell manufacturing milestone for clinical trial Sydney, Australia – 7 April 2015 •Successful manufacture of “off-the-shelf” stem cell therapy product, Progenza, for First- in-Human osteoarthritis trial•Demonstrates capacity to manufacture millions of therapeutic doses from a single donor•On track for trial approval in first-half of 2015
Poster: RiskVsReward (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15043270/single (Mcap: $20.9m)
PTX - Biotech [8/04/2015]
MC: $4.3m CASH: $2m approx Prescient Therapeutics is a clinical stage oncology company developing two novel drug candidates for the treatment of cancer. Perhaps the most interesting facet of this company is that two of its trials are funded by the US govt. The company holds an exclusive worldwide license to the novel anti-cancer compound PTX-100 (formerly known as GGTI-2418) for the treatment of multiple myeloma, breast and pancreatic cancer. The company plans to initiate Phase 1b/2 clinical trial of PTX-100 in multiple myeloma in H1 2015. Perhaps more excitinglyTX-200 is currently the subject of two pivotal trials in breast and ovarian cancer underway at prestigious US Cancer Centres. The first trial is a Phase 1b/2 trial in patients with platinum resistant ovarian cancer at the Moffitt Cancer Centre, an NCI-designated cancer hospital in Tampa, Florida. The second trial is a Phase 1b/2 study in breast cancer patients at the Montefiore Medical Centre, the academic medical centre and University Hospital for Albert Einstein College of Medicine in Bronx, New York. These trials are funded by grants from the U.S. Department of Defence and U.S. National Cancer Institute. Prescient is one of a very small number of ASX-listed biotechnology companies conducting clinical studies under an IND status in the US which bodes well for a very fast pathway to commercialisation. As an additional source of income: Prescient has licensed access to its Co-X-Gene™ platform technology to French biotechnology company Transgene for use in two immunotherapeutic products. With cash backing of just under half of MC with income stream and the financial backing of US Govt. This company is seriously undervalued IMO. A decent stream of trial news will see SP head north from here IMO
Poster: CaptainGoodvybes (STT Accuracy: 27.3% - Ranking No.16 ) http://hotcopper.com.au/posts/15044185/single (Mcap: $3.8m)
MLX - Diversified mining services company with key operations in Australia and Africa [7/04/2015]
MC: $14M Shares on Issue: 413 Million Top 20 own 73% Cash: $57.1 mil Earnings and Dividends Forecast (cps) 2014 2015 2016 2017 EPS 9.4 9.5 10.3 27.5 DPS 2.7 3.0 3.2 8.5 FA: Metals X Limited (MLX) is a diversified resource group with a portfolio of assets from exploration to production. MLX has interests in projects in Australia as well as having investment holdings across the mining industry with global reach from Madagascar to Mongolia. A major shareholder in AZK[13%].http://imagesignal.commsec.com.au/d...nZXNpZ25hbC9lcnJvcnBhZ2VzL3BkZmRlbGF5ZWQuanNw
Poster: Wazza3006 (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15034232/single (Mcap: $540.8m)
BML - Metals Explorer in Botswana (Ni, Cu, PGE’s and Au) [7/04/2015]
Market Cap – 8.5 Million (undiluted) – 14 Million (diluted) Cash 480k (At 31/12/14) – Cash Burn around 200k per qtr (see Qtrly’s) FA – Long Reason for FA at this time…..1.Completed maiden resource calculation (JORC) in Early April 2015 for Maibele North then…..2.MSA has also been commissioned to complete a Scoping Study at Maibele North to evaluate the economics of mining and processing the ore at BCL’s Selebi Phikwe plant. If this study is positive, a Feasibility Study will be completed as part of the requirement for a Mining Licence application.3.Also awaiting completed metallurgical testing as part of the Scoping Study to determine process recoveries and costs.4.Also commence a new drill program targeted at extending the known mineralisation in the areas still open to the west, east and at depth at Maibele North. Drilling is expected to commence very soon.
Poster: Globe_Trader (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15039993/single (Mcap: $8m)
CMY - Medical Cannabis [Canada] [7/04/2015]
Last traded SP: $0.004Market Cap: $5m Shares on issue: 1329.16m Industry: Materials• Capital Mining Limited (CMY) to acquire up to 49% of a Canadian licensed grower, manufacturer and distributor of medical cannabis products, Broken Coast Cannabis (BCC)• BCC is currently producing medical cannabis and generating revenue from sales.• Customer base growing at 20 retail patients per day plus increasing wholesale agreements.• BCC receives annual License renewal• BCC signs two wholesale contracts valued at C$1,435,000• CMY’s investment to fund increase in production capacity and growth in sales network.• CMY also to acquire 100% of Cannan Growers Inc (CGI)• Canada’s medical cannabis market to grow beyond CAD$1.3 billion in sales annually.• CMY to acquire 100% of U.S Hemp based products company NUTRAWERX INC. BCC currently has the capacity to produce 720,000 grams of cannabis annually. Through the proposed investment by CMY, BCC intends to increase production to 2,000,000 grams. Receiving between CAD$7-$10 per gram
. Nutrawerx projected to achieve significant market share of the USD$580m Hemp retail Market within 3 years. Nutrawerx has entered into a JV with Marketing Management INC (MMI) to develop branded mainstream Hemp products. MMI has a comprehensive list of Multi Billion dollar, high profile distribution companies. Cannan Growers Inc (CGI) are experts at compliant production methods for obtaining Medical Cannabis Licensing. All 3 acquisitions complement each other, they set CMY to become turnkey market leader of Medical Cannabis and hemp based retail space
Poster: Dazdog (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15039079/single (Mcap: $5.3m)
MOX - Explorer for minerals in South Aust [13/04/2015]
sp = 1.3c cash = $1.4M @ Dec 2014 shares = 214M MC = $2.7M Has formed a double bottom on the long term daily chart, bollies are tightening and a recent flattish base has formed
Poster: Marty386 (STT Accuracy: 38.7% - Ranking No.11 ) http://hotcopper.com.au/posts/15072510/single (Mcap: $2.8m)
VET - Consumer Services [13/04/2015]
Vocation Limited (VET) provides education, training and assessment activities leading to accredited outcomes offered by a registered training organisation ("RTO"). Market Cap: $36.6M Current sp: 15.5cTA - The share price has broken the most recent downtrend with a 24% share price increase on friday. VET at these prices has previously increased tens of percent in a day. It looks like it is time for the next leg up. - 15 day Moving average and 30 day Exponential Moving Average are about to cross and create a Golden Cross - There was a doji on Wednesday which indicates that there was indecision and a struggle between the buyers and sellers. - Significantly more buyers to sellers at the moment. It will be interesting to see if VET can rise from the ashes.
Poster: Ibza (STT Accuracy: 35.1% - Ranking No.13 ) http://hotcopper.com.au/posts/15072728/single (Mcap: $35.6m)
BCI - Iron Ore in the Pilbara WA [10/04/2015]
MC- $57.9 mill Cash – $107.5million - with debt $35.8million (31.3.2015 – Quarterly update) SP – 0.295 Increasing volume over past few days. RSI turning up. Borderline bullish engulfing candle today. Closed in top 25% of today’s range. Reversal anticipated (otherwise I wouldn’t be putting in the tip…doh!!!)
Poster: Trevor12 (STT Accuracy: 30.8% - Ranking No.15 ) http://hotcopper.com.au/posts/15061223/single (Mcap: $54m)
NXR - Biometrics [9/04/2015]
MC: $15m Broke upwards on increasing volume today after a low volume retrace from the recent highs. Bounced off both the rising trend line and previous support. Decent gains today and finished on its high - Should be some more in her over the next week days to weeks. ST target at least 9c to 9.5c before going on to have a crack at the recent 11.5c highs and beyond.
Poster: Toxxxic (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15052645/single (Mcap: $17.4m)
BOK - Gold in NSW and WA [8/04/2015]
MC: $17M MD & wife have substantial share holding 600 mil+Strong pennant formation. Upward trend since Dec 2014. Ready for next breakout. Could break 52 week high this month
Poster: Wazza3006 (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15043112/single (Mcap: $17.6m)
MLX - Diversified mining services company with key operations in Australia and Africa [7/04/2015]
MC: $14M Shares on Issue: 413 Million Top 20 own 73% Cash: $57.1 mil Earnings and Dividends Forecast (cps) 2014 2015 2016 2017 EPS 9.4 9.5 10.3 27.5 DPS 2.7 3.0 3.2 8.5Over 100% increase in share price in past three months. Strong chart - set to break 52 week high sp [$1.38 / 20/2/15] this month. Current SP $1.26
Poster: Wazza3006 (STT Accuracy: Unknown) http://hotcopper.com.au/posts/15034232/single (Mcap: $540.8m)